Literature DB >> 17764111

Testicular cancer: marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970.

Rob Verhoeven1, Saskia Houterman, Bart Kiemeney, Evert Koldewijn, Jan Willem Coebergh.   

Abstract

The aim of our study was to interpret the changing incidence, and to describe the mortality of patients with testicular cancer in the south of the Netherlands between 1970 and 2004. On the basis of data from the Eindhoven Cancer Registry and Statistics Netherlands, 5-year moving average standardised incidence and mortality rates were calculated. An age-period-cohort (APC) Poisson regression analysis was performed to disentangle time and birth cohort effects on incidence. The incidence rate remained stable for all ages at about 3 per 100,000 person-years until 1989 but increased annually thereafter by 4% to 6 in 2004. This increase can almost completely be attributed to an increase in localised tumours. The largest increase was found for seminoma testicular cancer (TC) patients aged 35-39 and non-seminoma TC patients aged 20-24 years. Relatively more localised and tumours with lymph node metastases were detected in the later periods. APC analysis showed the best fit with an age-cohort model. An increase in incidence of TC was found for birth cohorts since 1950. The mortality rate dropped from 1.0 per 100,000 person-years in 1970 to 0.3 in 2005, with a steep annual decline of 12% in the period 1979-1986. In conclusion, the increase in incidence of TC was strongly correlated with birth cohorts since 1945. The increase in incidence is possibly caused by in utero or early life exposure to a yet unknown risk factor. There was a steep decline in mortality in the period 1979-1986. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17764111     DOI: 10.1002/ijc.23061

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  A web tool for age-period-cohort analysis of cancer incidence and mortality rates.

Authors:  Philip S Rosenberg; David P Check; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-21       Impact factor: 4.254

2.  Age-period-cohort models in cancer surveillance research: ready for prime time?

Authors:  Philip S Rosenberg; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-24       Impact factor: 4.254

3.  Proportional hazards models and age-period-cohort analysis of cancer rates.

Authors:  Philip S Rosenberg; William F Anderson
Journal:  Stat Med       Date:  2010-05-20       Impact factor: 2.373

4.  Are incidence rates of adult leukemia in the United States significantly associated with birth cohort?

Authors:  Philip S Rosenberg; Katherine L Wilson; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-12       Impact factor: 4.254

5.  Association of marijuana use and the incidence of testicular germ cell tumors.

Authors:  Janet R Daling; David R Doody; Xiaofei Sun; Britton L Trabert; Noel S Weiss; Chu Chen; Mary L Biggs; Jacqueline R Starr; Sudhansu K Dey; Stephen M Schwartz
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

6.  Testicular cancer incidence predictions in Europe 2010-2035: A rising burden despite population ageing.

Authors:  Ariana Znaor; Niels E Skakkebaek; Ewa Rajpert-De Meyts; Mathieu Laversanne; Tomislav Kuliš; Jason Gurney; Diana Sarfati; Katherine A McGlynn; Freddie Bray
Journal:  Int J Cancer       Date:  2019-12-28       Impact factor: 7.316

Review 7.  Understanding variation in disease risk: the elusive concept of frailty.

Authors:  Odd O Aalen; Morten Valberg; Tom Grotmol; Steinar Tretli
Journal:  Int J Epidemiol       Date:  2014-12-12       Impact factor: 7.196

8.  Sperm cryopreservation incidence in men with testicular cancer: towards a stabilization in testicular cancer incidence? Results from the CECOS network.

Authors:  Marie Walschaerts; Louis Bujan; Cécile Chouquet; Valentine Rossi; Jean-Claude Juillard; Patrick Thonneau
Journal:  Basic Clin Androl       Date:  2018-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.